Effects of Coenzyme Q₁₀ Supplementation on Serum Values of Gamma-glutamyl transferase, Pseudocholinesterase, Bilirubin, Ferritin, and High-Sensitivity C-Reactive Protein in Women with Type 2 Diabetes

Abstract

Background Type 2 diabetes mellitus (T2DM) is a disease associated with increased oxidative stress which results from mitochondrial dysfunction. Coenzyme Q₁₀ (CoQ₁₀) is an essential antioxidant for energy production in mitochondria. The purpose of this randomized double-blind clinical trial study was to evaluate the effects of CoQ₁₀ supplementation on serum values of gamma-glutamyl transferase (GGT), pseudocholinesterase (PchE), bilirubin, ferritin, and high-sensitivity c-reactive protein (hs-CRP) and metabolic syndrome biomarkers in women with T2DM.

Material & Methods Eighty women with T2DM enrolled in this study. Thirty six of them were randomized in the drug group (receiving 100 mg/day of CoQ₁₀) and 44 women were randomized in placebo group. Intervention was continued for 12 weeks. In both groups 35 subjects finished the study and were included in the analysis. Serum levels of the variables were measured before and after supplementation.

Results Serum values of FBS (P=0.039), HOMA-IR (P=0.01), ferritin (P<0.001), total cholesterol (TC) (P=0.006), LDL-C (P=0.007) decreased and HDL-C (P=0.02) increased significantly in the drug group after intervention. Serum levels of triglyceride (P=0.09) decreased marginally in CoQ₁₀ group.

Conclusions The results of the current study had shown that after supplementation with 100 mg/day of CoQ₁₀ for 12 weeks, serum values of FBS, HOMA-IR, TC, LDL-C and ferritin were decreased and values of HDL-C were increased in women with T2DM.

Key words

type 2 diabetes - coenzyme Q₁₀ - butyrylcholinesterase - gamma-glutamyl transferase - ferritin

• References

• 1 Guerrero-Romero F, Rodriguez-Moran M, González-Ortiz M. et al. Insulin action and secretion in healthy Hispanic-Mexican first-degree relatives of subjects with type 2 diabetes. J Endocrinol Invest 2001; 24: 580-586
• 2 Kunutsor SK, Abbasi A, Adler AI. Gamma-glutamyl transferase and risk of type II diabetes: An updated systematic review and dose-response meta-analysis. Ann Epidemiol 2014; 24: 809-816
• 3 Suksomboon N, Poolsup N, Juanak N. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: A systematic review and meta-analysis. J Clin Pharm Ther 2015; 40: 413-418
• 4 Shen Q, Pierce JD. Supplementation of coenzyme Q10 among patients with type 2 diabetes mellitus. Healthcare (Basel) 2015; 296-309
• 5 Nadjarzadeh A, Sadeghi M, Amirjannati N. et al. Coenzyme Q10 improves seminal oxidative defense but does not affect on semen parameters in idiopathic oligoasthenoteratozoospermia: A randomized double-blind, placebo controlled trial. J Endocrinol Invest 2011; 34: e224-e228
• 6 Farsi F, Mohammadshahi M, Alavinejad P. et al. Functions of Coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: A double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr 2016; 35: 346-353
• 7 Haghighi S, Amini M, Pournaghshband Z. et al. Relationship between gamma-glutamyl transferase and glucose intolerance in first degree relatives of type 2 diabetics patients. J Res Med Sci 2011; 16: 123
• 8 Onur S, Niklowitz P, Jacobs G. et al. Ubiquinol reduces gamma glutamyltransferase as a marker of oxidative stress in humans. BMC Res Notes 2014; 7: 42
• 9 Santarpia L, Grandone I, Contaldo F. et al. Butyrylcholinesterase as a prognostic marker: A review of the literature. J Cachexia Sarcopenia Muscle 2013; 4: 31-39
• 10 Annapurna V, Senciall I, Davis A. et al Relationship between serum pseudocholinesterase and triglycerides in experimentally induced diabetes mellitus in rats. Diabetologia 1991; 34: 320-324
• 11 Rao AA, Sridhar GR, Das UN. Elevated butyrylcholinesterase and acetylcholinesterase may predict the development of type 2 diabetes mellitus and Alzheimer’s disease. Med Hypotheses 2007; 69: 1272-1276
• 12 Solecka J, Guśpiel A, Postek M. et al. New derivatives of 3, 4-dihydroisoquinoline-3-carboxylic acid with free-radical scavenging, D-amino acid oxidase, acetylcholinesterase and butyrylcholinesterase inhibitory activity. Molecules 2014; 19: 15866-15890
• 13 Hussan RM, Al-Khayat PDT. Relationship among Serum Level of Butyrylcholinesterase, Oxidative Stress and Lipid Profile in Premenopausal and Postmenopausal Iraqi Women. IJSER 2014; 5: 773-780
• 14 Hamamoto S, Kaneto H, Kamei S. et al. Low bilirubin levels are an independent risk factor for diabetic retinopathy and nephropathy in Japanese patients with type 2 diabetes. Diabetes Metab 2015; 41: 429-431
• 15 Chung JO, Cho DH, Chung DJ. et al. The duration of diabetes is inversely associated with the physiological serum bilirubin levels in patients with type 2 diabetes. Intern Med 2015; 54: 141-146
• 16 Sridhar G, Nirmala G, Apparao A. et al. Serum butyrylcholinesterase in type 2 diabetes mellitus: A biochemical and bioinformatics approach. Lipids Health Dis 2005; 4: 18
• 17 Lin L-Y, Kuo H-K, Hwang J-J. et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2009; 203: 563-568
• 18 Liu J, Dong H, Zhang Y. et al. Bilirubin increases insulin sensitivity by regulating cholesterol metabolism, adipokines and PPARγ levels. Sci Rep 2015; 5: 09886
• 19 Esfahani SA, Esmaeilzadeh E, Bagheri F. et al. The effect of co-enzyme q10 on acute liver damage in rats, a biochemical and pathological study. Hepat Mon 2013; 13: e13685
• 20 Momeni A, Behradmanesh MS, Kheiri S. et al. Serum ferritin has correlation with HbA1c in type 2 diabetic patients. Adv Biomed Res 2015; 4: 74
• 21 Bonfils L, Ellervik C, Friedrich N. et al. Fasting serum levels of ferritin are associated with impaired pancreatic beta cell function and decreased insulin sensitivity: A population-based study. Diabetologia 2015; 58: 523-533
• 22 Zhan Y, Tang Z, Yu J. Serum ferritin, diabetes, diabetes control, and insulin resistance. Acta Diabetol 2014; 51: 991-998
• 23 Kooncumchoo P, Sharma S, Porter J. et al. Coenzyme Q10 provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 2006; 28: 125-141
• 24 Devaraj S, Singh U, Jialal I. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol 2009; 20: 182
• 25 Iturry-Yamamoto G, Zago A, Moriguchi E. et al. Impact of metabolic syndrome and C-reactive protein on outcome after coronary stenting. J Endocrinol Invest 2009; 32: 383-386
• 26 Moazen M, Mazloom Z, Ahmadi A. et al. Effect of coenzyme Q10 on glycaemic control, oxidative stress and adiponectin in type 2 diabetes. J Pak Med Assoc 2015; 65: 404-408
• 27 Lee B-J, Huang Y-C, Chen S-J. et al. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 2012; 28: 767-772
• 28 Association AD . Diagnosis and classification of diabetes mellitus. Diabetes care 2014; 37: S81-S90
• 29 Hejazi ME, Modarresi-Ghazani F, Hamishehkar H. et al The Effect of Treatment of Vitamin D Deficiency on the Level of P-Selectin and hs‐CRP in Patients With Thromboembolism: A Pilot Randomized Clinical Trial. J Clin Pharmacol 2017; 57: 40-47
• 30 Heibashy M, El-Nahla A, Mazen G. et al. Assessment role of coenzyme Q10 on some physiological and biochemical parameters in resembling type II diabetic rats. Egypt J Basic Appl Physiol 2009; 8: 255-272
• 31 Karpińska J, Mikołuć B, Motkowski R. et al. HPLC method for simultaneous determination of retinol, α-tocopherol and coenzyme Q 10 in human plasma. J Pharm Biomed Anal 2006; 42: 232-236
• 32 Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care 2004; 27: 1487-1495
• 33 Nowotny K, Jung T, Höhn A. et al. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 2015; 5: 194-222
• 34 SHIGETA Y, IZUMI K. ABE H. Effect of coenzyme Q7 treatment on blood sugar and ketone bodies of diabetics. J Vitaminol 1966; 12: 293-298
• 35 Zahedi H, Eghtesadi S, Seifirad S. et al. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial. J Diabetes Metab Disord 2014; 13: 81
• 36 Singh R, Niaz M, Rastogi S. et al. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery. J Hum Hypertens 1999; 13: 203-208
• 37 Henriksen J, Andersen CB, Hother-Nielsen O. et al. Impact of ubiquinone (coenzyme Q10) treatment on glycaemic control, insulin requirement and well-being in patients with Type 1 diabetes mellitus. Diabet Med 1999; 16: 312-318
• 38 Eriksson J, Forsen T, Mortensen S. et al. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors 1999; 9: 315-318
• 39 Lim SC, Lekshminarayanan R, Goh SK. et al. The effect of coenzyme Q 10 on microcirculatory endothelial function of subjects with type 2 diabetes mellitus. Atherosclerosis 2008; 196: 966-969
• 40 Hodgson J, Watts G, Playford D. et al. Coenzyme Q10 improves blood pressure and glycaemic control: A controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 2002; 56: 1137
• 41 Mezawa M, Takemoto M, Onishi S. et al. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: An open label pilot study. Biofactors 2012; 38: 416-421
• 42 Kolahdouz MR, Hosseinzadeh-Attar M, Eshraghian M. et al. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol 2013; 59: 231-236
• 43 El-Hamid MA, El-Halim MS, Karima I. et al. Role of coenzyme Q10, metformin and rosiglitazone in treatment of experimental nonalcoholic steatohepatitis in rats. Tanta Med Sc J 2008; 3: 15e29
• 44 Samimi M, Zarezade Mehrizi M, Foroozanfard F. et al. The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol 2017; 86: 560-566
• 45 Fakhrabadi MA, Ghotrom AZ, Mozaffari-Khosravi H. et al. Effect of Coenzyme Q10 on oxidative stress, glycemic control and inflammation in diabetic neuropathy: A double blind randomized clinical Trial. Int J Vitam Nutr Res 2014; 84: 252-260
• 46 Amin MM, Asaad GF, Salam RMA. et al. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: Modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PloS one 2014; 9: e89169
• 47 Sena CM, Nunes E, Gomes A. et al. Supplementation of coenzyme Q 10 and α-tocopherol lowers glycated hemoglobin level and lipid peroxidation in pancreas of diabetic rats. Nutr Res 2008; 28: 113-121
• 48 Watts G, Playford D, Croft K. et al. Coenzyme Q10 improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus. Diabetologia 2002; 45: 420-426
• 49 Mohseni M, Vafa MR, Hajimiresmail SJ. et al. Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction. Iran Red Crescent Med J 2014; 16: e16433
• 50 Mehrdadi P, Mohammadi RK, Alipoor E. et al. The effect of coenzyme q10 supplementation on circulating levels of novel adipokine adipolin/CTRP12 in overweight and obese patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2017; 125: 156-162
• 51 Alam MA, Rahman MM. Mitochondrial dysfunction in obesity: Potential benefit and mechanism of Co-enzyme Q10 supplementation in metabolic syndrome. J Diabetes Metab Disord 2014; 13: 60
• 52 Forlani G, Di Bonito P, Mannucci E. et al Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. J Endocrinol Invest 2008; 31: 146-152
• 53 Kalpravidh RW, Wichit A, Siritanaratkul N. et al. Effect of coenzyme Q10 as an antioxidant in β-thalassemia/Hb E patients. Biofactors 2005; 25: 225-234
• 54 Eisenstein RS. Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr 2000; 20: 627-662
• 55 Liu B-w, Xuan X-m, Liu J-r. et al The relationship between serum ferritin and insulin resistance in different glucose metabolism in nonobese Han adults. Int J Endocrinol 2015; 2015: 642194 doi:10.1155/2015/642194
• 56 Kalender Y, Uzunhisarcikli M, Ogutcu A. et al. Effects of diazinon on pseudocholinesterase activity and haematological indices in rats: the protective role of vitamin E. Environ Toxicol Pharmacol 2006; 22: 46-51
• 57 ALTUNTAŞ İ, DELİBAŞ N. The effects of fenthion on lipid peroxidation and some liver enzymes: the possible protective role of vitamins E and C. Turk J Med Sci 2002; 32: 293-297